Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabil Adra

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
The Urologic Clinics of North America|July 7, 2019
High-Dose Chemotherapy and Autologous Stem Cell TransplantNabil Adra, Rafat Abonour
Current Opinion in Oncology|March 26, 2023
Challenges in the management of relapsed germ cell tumorsTareq Salous, Nabil Adra
Current Oncology Reports|February 3, 2022
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell TumorsJennifer King, Nabil Adra
Current Opinion in Oncology|April 4, 2024
Current outstanding challenges in germ cell tumorsTareq Salous, Nabil Adra
Future Oncology (London, England)|November 13, 2019
Salvage therapy for relapsed testicular cancer: a need for consensusVaibhav Agrawal, Nabil Adra
Oncotarget|October 21, 2017
Salvage therapy for relapsed testicular cancerNabil Adra, Lawrence H Einhorn
Current Opinion in Oncology|March 11, 2025
Novel therapeutics in refractory germ cell tumorsNoah H Richardson, Nabil Adra
Oncotarget|November 8, 2017
Salvage therapy for relapsed testicular cancerNabil Adra, Lawrence H Einhorn
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Testicular cancer updateNabil Adra, Lawrence H Einhorn
Clinical Genitourinary Cancer|January 24, 2017
Unclassified Renal Cell Carcinoma With Significant Response to NivolumabNabil Adra, Liang Cheng, Roberto Pili
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
The Urologic Clinics of North America|July 7, 2019
High-Dose Chemotherapy and Autologous Stem Cell TransplantNabil Adra, Rafat Abonour
Current Opinion in Oncology|March 26, 2023
Challenges in the management of relapsed germ cell tumorsTareq Salous, Nabil Adra
Current Oncology Reports|February 3, 2022
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell TumorsJennifer King, Nabil Adra
Current Opinion in Oncology|April 4, 2024
Current outstanding challenges in germ cell tumorsTareq Salous, Nabil Adra
Future Oncology (London, England)|November 13, 2019
Salvage therapy for relapsed testicular cancer: a need for consensusVaibhav Agrawal, Nabil Adra
Oncotarget|October 21, 2017
Salvage therapy for relapsed testicular cancerNabil Adra, Lawrence H Einhorn
Current Opinion in Oncology|March 11, 2025
Novel therapeutics in refractory germ cell tumorsNoah H Richardson, Nabil Adra
Oncotarget|November 8, 2017
Salvage therapy for relapsed testicular cancerNabil Adra, Lawrence H Einhorn
Clinical Advances in Hematology & Oncology : H&O|June 8, 2017
Testicular cancer updateNabil Adra, Lawrence H Einhorn
Clinical Genitourinary Cancer|January 24, 2017
Unclassified Renal Cell Carcinoma With Significant Response to NivolumabNabil Adra, Liang Cheng, Roberto Pili
Pageof 10